Antibodies Against SARS-CoV-2 in Breast Milk Differ Between Vaccinated and Infected Mothers

All antibodies against SARS-CoV-2 found in breast milk neutralized the virus.

Written byRoni Dengler, PhD
| 3 min read
Antibodies in breastmilk from SARS-CoV-2 infection or mRNA vaccination neutralize the virus.
Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Messenger RNA (mRNA) vaccines developed in response to the ongoing COVID-19 pandemic elicit strong immune responses and provide protection against the virus. But how vaccination-induced protection compares with immunization remains unclear, especially in regard to parental antibodies in human milk.

Now, researchers report that antibodies in human breast milk from vaccinated women were dominantly IgG, the smallest but most common type of antibody. In contrast, antibodies against COVID-19 in breast milk from women infected with SARS-CoV-2 were mostly IgA, which typically reside in the nose, respiratory tract, and other mucosal areas. Although the antibodies differed, both types neutralized the virus, suggesting that breast milk likely provides some degree of protection to infants.

Kirsi Jarvinen-Seppo, a pediatric allergist-immunologist, and Bridget Young, a human milk scientist, both at the University of Rochester School of Medicine and Dentistry, knew from previous research that the SARS-CoV-2 virus does not pass from mother to infant ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies